Sunday, March 1, 2015

Adjuvant VEGF Blockers Disappoint in Kidney Cancer

(MedPage Today) -- Survival no better with post-surgical sunitinib or sorafenib than with placebo.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)